BACKGROUND: Non-psychotropic Cannabis sativa L. chemotypes have gained increasing interest due to their diverse profiles of bioactive compounds. While cannabinoids such as cannabidiol (CBD), cannabigerol (CBG), are known for their biological effects, the role of other cannabinoids such cannabichromene (CBC) remains underexplored as for chemotype V, which lacks in cannabinoids but is characterized by other minor phytochemicals. OBJECTIVE: This study aimed to evaluate the individual and combined contributions of cannabinoids and non-cannabinoid phenolics to the antioxidant, antimicrobial, and anti-inflammatory properties of extracts derived from four C. sativa chemotypes, including a cannabinoid-free variant as a comparison. METHODS: Ethanolic extracts were obtained from four hemp chemotypes: CBD-rich (CS1), CBG-rich (CS2), CBC-rich (CS3), and cannabinoid-free (CS4). Phytochemical profiling was conducted using UHPLC-HRMS. Antioxidant properties were assessed via DPPH, ABTS, and FRAP assays. Antimicrobial activity was tested against Gram-positive and Gram-negative bacteria through MIC, MBC, and time-kill assays. Anti-inflammatory activity was evaluated in LPS-stimulated RAW 264.7 macrophages via gene expression analysis of pro- and anti-inflammatory mediators (IL1b, IL6, Cox2, IL10, IL1Ra). RESULTS: Phytochemical analysis confirmed the chemotype-specific profiles, with CS3 showing the highest levels of canniprene and the early discovered 5-methoxy-dihydrodenbinobin. Antioxidant assays revealed that cannabinoids were the main contributors to radical scavenging capacity, though CS3 exhibited additional ferric ion reducing power likely due to non-cannabinoid phenolics. Antibacterial activity was confined to Gram-positive bacteria, where CS1 showed the highest efficacy, and CS4 showed no activity, highlighting the critical role of cannabinoids. All extracts reduced LPS-induced Il1b, Il6, and Cox2 gene expression, but only cannabinoid-rich extracts upregulated the anti-inflammatory cytokines IL10 and IL1Ra, indicating a cannabinoid-dependent effect. CONCLUSION: Both cannabinoids and non-cannabinoid phenolics contribute to the biological activity of Cannabis sativa extracts, with cannabinoids playing a central role in antimicrobial responses and stronger anti-inflammatory effect as a pure cannabinoid or as an extract. From this point of view, the cannabinoid-free chemotype V could be a valuable functional control for isolating the effects of cannabinoids, reinforcing the need for integrative analyses in evaluating the therapeutic potential of cannabis-derived formulations. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s42238-025-00336-1.

Center for Translational Research on Autoimmune and Allergic Diseases University of Piemonte Orientale C so Trieste 15 A Novara 28100 Italy

Department of Food Analysis and Nutrition University of Chemistry and Technology Prague Technická 5 Prague 6 166 28 Czech Republic

Department of Pharmaceutical Sciences University of Piemonte Orientale L go Donegani 2 Novara 28100 Italy

Zobrazit více v PubMed

Aiemsaard J, Singh R, Borlace GN, Sripanidkulchai B, Tabboon P, Thongkham E. Antibacterial activity of cannabis extract (Cannabis sativa L. subsp. Indica (Lam.)) against canine skin infection bacterium Staphylococcus Pseudintermedius. ScienceAsia. 2022;48(3):348. 10.2306/scienceasia1513-1874.2022.053. DOI

Allegrone G, Pollastro F, Magagnini G, Taglialatela-Scafati O, Seegers J, Koeberle A, Werz O, Appendino G. The bibenzyl canniprene inhibits the production of Pro-Inflammatory eicosanoids and selectively accumulates in some cannabis sativa strains. J Nat Prod. 2017;80(3):731–4. 10.1021/acs.jnatprod.6b01126. PubMed DOI

Aqawi M, Sionov RV, Gallily R, Friedman M, Steinberg D. Anti-Bacterial properties of Cannabigerol toward Streptococcus mutans. Front Microbiol. 2021;12. 10.3389/fmicb.2021.656471. PubMed PMC

Borroto Fernandez E, Peterseil V, Hackl G, Menges S, de Meijer E, Staginnus C. Distribution of chemical phenotypes (Chemotypes) in European agricultural hemp (Cannabis sativa L.) cultivars. J Forensic Sci. 2020;65(3):715–21. 10.1111/1556-4029.14242. PubMed DOI

de Meijer EP. The chemical phenotypes (Chemotypes) of cannabis. Handbook of cannabis. Oxford University Press. 2014;89–110. 10.1093/acprof:oso/9780199662685.003.0005.

de Meijer EP, Hammond KM, Micheler M. The inheritance of chemical phenotype in DOI

Denyer SP, Maillard JY. Cellular impermeability and uptake of biocides and antibiotics in gram-negative bacteria. Symposium Series (Society for Applied Microbiology), 2002;31:35S-45S. PubMed

Fiorentino N, Formisano C, Delfine S, Chianese G. Editorial: environmental and agronomic factors affecting the chemical composition and biological activity of cannabis extracts. Front Plant Sci. 2024;15. 10.3389/fpls.2024.1407262. PubMed PMC

Gojani EG, Wang B, Li D-P, Kovalchuk O, Kovalchuk I. Anti-Inflammatory effects of minor cannabinoids CBC, THCV, and CBN in human macrophages. Molecules. 2023;28(18). 10.3390/molecules28186487. Article 18. PubMed PMC

Iannotti FA, Vitale RM. The endocannabinoid system and ppars: focus on their signalling crosstalk. Action Transcriptional Regul Cells. 2021;10(3). 10.3390/cells10030586. PubMed PMC

Kim J-H, Hong M, Han J-H, Ryu BR, Lim YS, Lim JD, Kim CH, Lee S-U, Kwon T-H. In vitro and in vivo Anti-Inflammatory effects of Cannabidiol isolated from novel hemp (Cannabis sativa L.) cultivar Pink pepper. Molecules. 2023;28(18). 10.3390/molecules28186439. Article 18. PubMed PMC

Koltai H, Namdar D. Cannabis phytomolecule entourage: from domestication to medical use. Trends Plant Sci. 2020;25(10):976–84. 10.1016/j.tplants.2020.04.007. PubMed DOI

Martini S, Gemma A, Ferrari M, Cosentino M, Marino F. Effects of Cannabidiol on innate immunity: experimental evidence and clinical relevance. Int J Mol Sci. 2023;24(4). 10.3390/ijms24043125. PubMed PMC

O’Croinin C, Garcia Guerra A, Doschak MR, Löbenberg R, Davies NM. Therapeutic potential and predictive pharmaceutical modeling of Stilbenes in cannabis sativa. Pharmaceutics. 2023;15(7). 10.3390/pharmaceutics15071941. Article 7. PubMed PMC

Rakotoarivelo V, Mayer TZ, Simard M, Flamand N, Di Marzo V. The impact of the CB2 cannabinoid receptor in inflammatory diseases: an update. Molecules. 2024;29(14). 10.3390/molecules29143381. PubMed PMC

Russo EB. The case for the entourage effect and conventional breeding of clinical cannabis: no strain. No Gain Front Plant Sci. 2019;9. 10.3389/fpls.2018.01969. PubMed PMC

Salamone S, Waltl L, Pompignan A, Grassi G, Chianese G, Koeberle A, Pollastro F. Phytochemical characterization of cannabis sativa L. Chemotype V reveals three new dihydrophenanthrenoids that favorably reprogram lipid mediator biosynthesis in macrophages. Plants. 2022;11(16). 10.3390/plants11162130. Article 16. PubMed PMC

Silva RL, Silveira GT, Wanderlei CW, Cecilio NT, Maganin AGM, Franchin M, Marques LMM, Lopes NP, Crippa JA, Guimarães FS, Alves-Filho JCF, Cunha FQ, Cunha TM. DMH-CBD, a Cannabidiol analog with reduced cytotoxicity, inhibits TNF production by targeting NF-kB activity dependent on A2A receptor. Toxicol Appl Pharmcol. 2019;368:63–71. 10.1016/j.taap.2019.02.011. PubMed DOI

Valizadehderakhshan M, Shahbazi A, Kazem-Rostami M, Todd MS, Bhowmik A, Wang L. Extraction of cannabinoids from cannabis sativa L. (Hemp)—Review Agric. 2021;11(5). 10.3390/agriculture11050384.

Werz O, Seegers J, Schaible AM, Weinigel C, Barz D, Koeberle A, Allegrone G, Pollastro F, Zampieri L, Grassi G, Appendino G. Cannflavins from hemp sprouts, a novel cannabinoid-free hemp food product, target microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase. PharmaNutrition. 2014;2(3):53–60. 10.1016/j.phanu.2014.05.001. DOI

Wood JS, Gordon WH, Morgan JB, Williamson RT. Cannabicitran: its unexpected racemic nature and potential origins. Chirality. 2023;35(9):540–8. 10.1002/chir.23571. PubMed DOI

Zhang Z, Wang R, Li M, Lu M. Current insights and trends in atopic dermatitis and microbiota interactions: A systematic review and bibliometric analysis. Front Microbiol. 2025;16. 10.3389/fmicb.2025.1613315. PubMed PMC